216 related articles for article (PubMed ID: 12799025)
1. Dynamics of immune cell trafficking in interferon-beta treated multiple sclerosis patients.
Hartrich L; Weinstock-Guttman B; Hall D; Badgett D; Baier M; Patrick K; Feichter J; Hong J; Ramanathan M
J Neuroimmunol; 2003 Jun; 139(1-2):84-92. PubMed ID: 12799025
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte subpopulations, oxidative burst and apoptosis in peripheral blood cells of patients with multiple sclerosis-effect of interferon-beta.
Mix E; Stefan K; Höppner J; Klauer T; Zettl UK; Strauss U; Meyer-Rienecker HJ; Rolfs A
Autoimmunity; 2003 Aug; 36(5):291-305. PubMed ID: 14567559
[TBL] [Abstract][Full Text] [Related]
3. Natural killer cells in relapsing-remitting MS: effect of treatment with interferon beta-1B.
Kastrukoff LF; Morgan NG; Zecchini D; White R; Petkau AJ; Satoh J; Paty DW
Neurology; 1999 Jan; 52(2):351-9. PubMed ID: 9932956
[TBL] [Abstract][Full Text] [Related]
4. Plasmacytoid dendritic cells in multiple sclerosis: intracerebral recruitment and impaired maturation in response to interferon-beta.
Lande R; Gafa V; Serafini B; Giacomini E; Visconti A; Remoli ME; Severa M; Parmentier M; Ristori G; Salvetti M; Aloisi F; Coccia EM
J Neuropathol Exp Neurol; 2008 May; 67(5):388-401. PubMed ID: 18431257
[TBL] [Abstract][Full Text] [Related]
5. Statins as immunomodulators: comparison with interferon-beta 1b in MS.
Neuhaus O; Strasser-Fuchs S; Fazekas F; Kieseier BC; Niederwieser G; Hartung HP; Archelos JJ
Neurology; 2002 Oct; 59(7):990-7. PubMed ID: 12370451
[TBL] [Abstract][Full Text] [Related]
6. Effect of interferon beta-1a on B7.1 and B7.2 B-cell expression and its impact on T-cell proliferation.
Huang H; Ito K; Dangond F; Dhib-Jalbut S
J Neuroimmunol; 2013 May; 258(1-2):27-31. PubMed ID: 23489746
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of survivin expression in T lymphocytes after interferon beta-1a treatment in patients with multiple sclerosis.
Sharief MK; Semra YK
Arch Neurol; 2002 Jul; 59(7):1115-21. PubMed ID: 12117359
[TBL] [Abstract][Full Text] [Related]
8. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
[TBL] [Abstract][Full Text] [Related]
9. Phenotyping analysis of peripheral blood leukocytes in patients with multiple sclerosis.
Paź A; Fiszer U; Zaborski J; Korlak J; Członkowski A; Członkowska A
Eur J Neurol; 1999 May; 6(3):347-52. PubMed ID: 10210917
[TBL] [Abstract][Full Text] [Related]
10. The immunostimulant RU41740 from Klebsiella pneumoniae activates human cells in whole blood to potentially stimulate innate and adaptive immune responses.
Pedraza-Sánchez S; González-Hernández Y; Escobar-Gutiérrez A; Ramachandra L
Int Immunopharmacol; 2006 Apr; 6(4):635-46. PubMed ID: 16504927
[TBL] [Abstract][Full Text] [Related]
11. Time-course analysis of CD25 and HLA-DR expression on lymphocytes in interferon-beta 1b-treated multiple sclerosis patients.
Ferrarini AM; Sivieri S; Buttarello M; Facchinetti A; Perini P; Gallo P
Mult Scler; 1998 Jun; 4(3):174-7. PubMed ID: 9762669
[TBL] [Abstract][Full Text] [Related]
12. CD45RA+ ICAM-3+ lymphocytes in interferon-beta1b-treated and -untreated patients with relapsing-remitting multiple sclerosis.
Chatzimanolis N; Kraus J; Bauer R; Engelhardt B; Bregenzer T; Kuehne BS; Tofighi J; Laske C; Stolz E; Blaes F; Voigt K; Traupe H; Kaps M; Oschmann P
Acta Neurol Scand; 2004 Dec; 110(6):377-85. PubMed ID: 15527450
[TBL] [Abstract][Full Text] [Related]
13. Interferon-beta modulates bone-associated cytokines and osteoclast precursor activity in multiple sclerosis patients.
Weinstock-Guttman B; Hong J; Santos R; Tamaño-Blanco M; Badgett D; Patrick K; Baier M; Feichter J; Gallagher E; Garg N; Ramanathan M
Mult Scler; 2006 Oct; 12(5):541-50. PubMed ID: 17086898
[TBL] [Abstract][Full Text] [Related]
14. Repopulation of T, B, and NK cells following alemtuzumab treatment in relapsing-remitting multiple sclerosis.
Gilmore W; Lund BT; Li P; Levy AM; Kelland EE; Akbari O; Groshen S; Cen SY; Pelletier D; Weiner LP; Javed A; Dunn JE; Traboulsee AL
J Neuroinflammation; 2020 Jun; 17(1):189. PubMed ID: 32539719
[TBL] [Abstract][Full Text] [Related]
15. Effects of interferon-beta 1a on the hypothalamic-pituitary-adrenal axis, leukocyte distribution and mood states in multiple sclerosis patients: results of a 1-year follow-up study.
Goebel MU; Czolbe F; Becker H; Janssen OE; Schedlowski M; Limmroth V
Eur Neurol; 2005; 53(4):182-7. PubMed ID: 15947464
[TBL] [Abstract][Full Text] [Related]
16. Increased CD80(+) B cells in active multiple sclerosis and reversal by interferon beta-1b therapy.
Genç K; Dona DL; Reder AT
J Clin Invest; 1997 Jun; 99(11):2664-71. PubMed ID: 9169496
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory effects of interferon-beta-1b in patients with multiple sclerosis.
Ossege LM; Sindern E; Patzold T; Malin JP
Int Immunopharmacol; 2001 Jun; 1(6):1085-100. PubMed ID: 11407304
[TBL] [Abstract][Full Text] [Related]
18. Killer-cell immunoglobulin-like receptor expression on lymphocyte subsets in multiple sclerosis patients treated with interferon-β: evaluation as biomarkers for clinical response.
García-León JA; López-Gómez C; Orpez-Zafra T; Reyes-Garrido V; Marín-Bañasco C; Oliver-Martos B; Fernández O; Leyva L
CNS Drugs; 2014 Jun; 28(6):559-70. PubMed ID: 24599774
[TBL] [Abstract][Full Text] [Related]
19. Natural killer receptors distribution in multiple sclerosis: Relation to clinical course and interferon-beta therapy.
Martínez-Rodríguez JE; Saez-Borderías A; Munteis E; Romo N; Roquer J; López-Botet M
Clin Immunol; 2010 Oct; 137(1):41-50. PubMed ID: 20580616
[TBL] [Abstract][Full Text] [Related]
20. Immune regulatory properties and interactions of copolymer-I and beta-interferon 1a in multiple sclerosis.
Zang Y; Hong J; Robinson R; Li S; Rivera VM; Zhang JZ
J Neuroimmunol; 2003 Apr; 137(1-2):144-53. PubMed ID: 12667659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
